Improving preprocedure antithrombotic management: Implementation and sustainment of a best practice alert and pharmacist referral process.
anticoagulation
anticoagulation clinic
endoscopy
pharmacist
preprocedure management
quality improvement
Journal
Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
24
02
2021
revised:
26
04
2021
accepted:
24
05
2021
entrez:
23
7
2021
pubmed:
24
7
2021
medline:
24
7
2021
Statut:
epublish
Résumé
Electronic medical record-based interventions such as best practice alerts, or reminders, have been proposed to improve evidence-based medication prescribing. Formal implementation evaluation including long-term sustainment are not commonly reported. Preprocedural medication management is often a complex issue for patients taking antithrombotic medications. We implemented a best practice alert (BPA) that recommended referral to an anticoagulation clinic before outpatient elective gastrointestinal (GI) endoscopies. Eligible patients were taking an oral anticoagulant (warfarin or direct oral anticoagulant [DOAC]) and/or antiplatelet medications. Patients referred to the anticoagulation clinic were compared to those managed by the ordering provider. Outcomes assessed included guideline-adherent drug management before endoscopy, documentation of a medication management plan, guideline-adherent rates of bridging for high-risk patients taking warfarin, and evaluation for sustained use of BPA. Eighty percent of patients (553/691) were referred to the anticoagulation clinic during the initial 13-month study period. Most referrals came from gastroenterologists (397/553; 71.8%) followed by primary care providers (127/554; 22.9%). Patients referred had improved rates of guideline-adherent medication management compared to those who were not referred (97.4% vs 91.0%; Implementation of a BPA before elective outpatient GI endoscopies was associated with improved rates of guideline-adherent medication management and documented management plan, while streamlining preprocedural medication management.
Sections du résumé
BACKGROUND
BACKGROUND
Electronic medical record-based interventions such as best practice alerts, or reminders, have been proposed to improve evidence-based medication prescribing. Formal implementation evaluation including long-term sustainment are not commonly reported. Preprocedural medication management is often a complex issue for patients taking antithrombotic medications.
METHODS
METHODS
We implemented a best practice alert (BPA) that recommended referral to an anticoagulation clinic before outpatient elective gastrointestinal (GI) endoscopies. Eligible patients were taking an oral anticoagulant (warfarin or direct oral anticoagulant [DOAC]) and/or antiplatelet medications. Patients referred to the anticoagulation clinic were compared to those managed by the ordering provider. Outcomes assessed included guideline-adherent drug management before endoscopy, documentation of a medication management plan, guideline-adherent rates of bridging for high-risk patients taking warfarin, and evaluation for sustained use of BPA.
RESULTS
RESULTS
Eighty percent of patients (553/691) were referred to the anticoagulation clinic during the initial 13-month study period. Most referrals came from gastroenterologists (397/553; 71.8%) followed by primary care providers (127/554; 22.9%). Patients referred had improved rates of guideline-adherent medication management compared to those who were not referred (97.4% vs 91.0%;
CONCLUSION
CONCLUSIONS
Implementation of a BPA before elective outpatient GI endoscopies was associated with improved rates of guideline-adherent medication management and documented management plan, while streamlining preprocedural medication management.
Identifiants
pubmed: 34296057
doi: 10.1002/rth2.12558
pii: S2475-0379(22)01419-4
pmc: PMC8285271
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12558Subventions
Organisme : NHLBI NIH HHS
ID : K01 HL135392
Pays : United States
Informations de copyright
© 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).
Références
J Am Med Inform Assoc. 2020 Jun 1;27(6):893-900
pubmed: 32337561
JAMA Cardiol. 2016 Dec 1;1(9):1076-1077
pubmed: 27627046
Am J Hypertens. 2019 Jan 1;32(1):70-76
pubmed: 30346480
Chest. 2005 May;127(5):1515-22
pubmed: 15888822
Obstet Gynecol. 2015 Aug;126(2):333-337
pubmed: 26241423
JAMA Netw Open. 2020 Feb 5;3(2):e1920548
pubmed: 32022882
BMC Med Inform Decis Mak. 2018 Jul 24;18(1):69
pubmed: 30041647
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):182-5
pubmed: 26933047
Vasc Med. 2018 Jun;23(3):232-240
pubmed: 29600737
Chest. 2020 Oct;158(4):1734-1741
pubmed: 32428510
BMJ Qual Saf. 2014 Mar;23(3):187-95
pubmed: 23708438
J Gen Intern Med. 2021 Jan;36(1):178-185
pubmed: 32865770
JAMA Netw Open. 2018 Jun 1;1(2):e180243
pubmed: 30646067
Am J Med. 2019 Apr;132(4):525-529
pubmed: 30521795
Eur J Heart Fail. 2017 Oct;19(10):1284-1293
pubmed: 28580625
Eur J Heart Fail. 2016 May;18(5):503-11
pubmed: 26869252
Thromb Res. 2019 Oct;182:167-174
pubmed: 31494438
J Thromb Thrombolysis. 2018 Jul;46(1):7-11
pubmed: 29605836
Eur J Heart Fail. 2018 Sep;20(9):1326-1334
pubmed: 29578280
BMJ Qual Saf. 2020 Jan;29(1):52-59
pubmed: 31320497
Am J Cardiol. 2017 Oct 15;120(8):1223-1229
pubmed: 28822562